|   
 | 
| Public Act 096-1078 
 | 
| | SB2931 Enrolled | LRB096 17757 KTG 35199 b | 
 | 
| 
 
 | 
|     AN ACT concerning public aid.
 | 
|     Be it enacted by the People of the State of Illinois,
  | 
| represented in the General Assembly:
 | 
|     Section 1. Short title. This Act may be cited as the  | 
| Pediatric Palliative Care Act.
 | 
|     Section 5. Legislative findings. The General Assembly  | 
| finds as follows: | 
|         (1) Each year, approximately 1,185 Illinois children  | 
| are diagnosed with a potentially life-limiting illness. | 
|         (2) There are many barriers to the provision of  | 
| pediatric palliative services, the most significant of  | 
| which include the following: (i) challenges in predicting  | 
| life expectancy; (ii) the reluctance of families and  | 
| professionals to acknowledge a child's incurable  | 
| condition; and (iii) the lack of an appropriate,  | 
| pediatric-focused reimbursement structure leading to  | 
| insufficient community-based resources. | 
|         (3) It is tremendously difficult for physicians to  | 
| prognosticate pediatric life expectancy due to the  | 
| resiliency of children. In addition, parents are rarely  | 
| prepared to cease curative efforts in order to receive  | 
| hospice or palliative care.  Community-based pediatric  | 
| palliative services, however, keep children out of the  | 
|  | 
| hospital by managing many symptoms in the home setting,  | 
| thereby improving childhood quality of life while  | 
| maintaining budget neutrality.
 | 
|         (4) Pediatric palliative programming can, and should,  | 
| be administered in a cost neutral fashion. Community-based  | 
| pediatric palliative care allows for children and families  | 
| to receive pain and symptom management and psychosocial  | 
| support in the comfort of the home setting, thereby  | 
| avoiding excess spending for emergency room visits and  | 
| certain hospitals. The National Hospice and Palliative  | 
| Care Organization's pediatric task force reported during  | 
| 2001 that the average cost per child per year, cared for  | 
| primarily at home, receiving comprehensive palliative and  | 
| life prolonging services concurrently, is $16,177,  | 
| significantly less than the $19,000 to $48,000 per child  | 
| per year when palliative programs are not utilized.
 | 
|     Section 10. Definition. In this Act, "Department" means the  | 
| Department of Healthcare and Family Services.
 | 
|     Section 15. Pediatric palliative care pilot program. The  | 
| Department shall develop a pediatric palliative care pilot  | 
| program under which a qualifying child as defined in Section 25  | 
| may receive community-based pediatric palliative care from a  | 
| trained interdisciplinary team while continuing to pursue  | 
| aggressive curative treatments for a potentially life-limiting  | 
|  | 
| illness under the benefits available under Article V of the  | 
| Illinois Public Aid Code.   
 | 
|     Section 20. Federal waiver or State Plan amendment. The  | 
| Department shall submit the necessary application to the  | 
| federal Centers for Medicare and Medicaid Services for a waiver  | 
| or State Plan amendment to implement the pilot program  | 
| described in this Act.  If the application is in the form of a  | 
| State Plan amendment, the State Plan amendment shall be filed  | 
| prior to December 31, 2010. If the Department does not submit a  | 
| State Plan amendment prior to December 31, 2010, the pilot  | 
| program shall be created utilizing a waiver authority. The  | 
| waiver request shall be included in any appropriate waiver  | 
| application renewal submitted prior to December 31, 2011, or  | 
| shall be submitted as an independent 1915(c) Home and Community  | 
| Based Medicaid Waiver within that same time period.  After  | 
| federal approval is secured, the Department shall implement the  | 
| waiver or State Plan amendment within 12 months of the date of  | 
| approval. By federal requirement, the application for a 1915  | 
| (c) Medicaid waiver program must demonstrate cost neutrality  | 
| per the formula laid out by the Centers for Medicare and  | 
| Medicaid Services. The Department shall not draft any rules in  | 
| contravention of this timetable for pilot program development  | 
| and implementation.   This pilot program shall be implemented  | 
| only to the extent that federal financial participation is  | 
| available.
 | 
|  | 
|     Section 25. Qualifying child.  | 
|     (a) For the purposes of this Act, a qualifying child is a  | 
| person under 18 years of age who is enrolled in the medical  | 
| assistance program under Article V of the Illinois Public Aid  | 
| Code and suffers from a potentially life-limiting medical  | 
| condition, as defined in subsection (b).  A child who is  | 
| enrolled in the pilot program prior to the age 18 may continue  | 
| to receive services under the pilot program until the day  | 
| before his or her twenty-first birthday.
 | 
|     (b) The Department, in consultation with interested  | 
| stakeholders, shall determine the potentially life-limiting  | 
| medical conditions that render a pediatric medical assistance  | 
| recipient eligible for the pilot program under this Act. Such  | 
| medical conditions shall include, but need not be limited to,  | 
| the following: | 
|         (1) Cancer (i) for which there is no known effective  | 
| treatment, (ii) that does not respond to conventional  | 
| protocol, (iii) that has progressed to an advanced stage,  | 
| or (iv) where toxicities or other complications prohibit  | 
| the administration of curative therapies. | 
|         (2) End-stage lung disease, including but not limited  | 
| to cystic fibrosis, that results in dependence on  | 
| technology, such as mechanical ventilation. | 
|         (3) Severe neurological conditions, including, but not  | 
| limited to, hypoxic ischemic encephalopathy, acute brain  | 
|  | 
| injury, brain infections and inflammatory diseases, or  | 
| irreversible severe alteration of mental status, with one  | 
| of the following co-morbidities: (i) intractable seizures  | 
| or (ii) brainstem failure to control breathing or other  | 
| automatic physiologic functions. | 
|         (4) Degenerative neuromuscular conditions, including,  | 
| but not limited to, spinal muscular atrophy, Type I or II,  | 
| or Duchenne Muscular Dystrophy, requiring technological  | 
| support. | 
|         (5) Genetic syndromes, such as Trisomy 13 or 18, where  | 
| (i) it is more likely than not that the child will not live  | 
| past 2 years of age or (ii) the child is severely  | 
| compromised with no expectation of long-term survival. | 
|         (6) Congenital or acquired end-stage heart disease,  | 
| including but not limited to the following: (i) single  | 
| ventricle disorders, including hypoplastic left heart  | 
| syndrome; (ii) total anomalous pulmonary venous return,  | 
| not suitable for curative surgical treatment; and (iii)  | 
| heart muscle disorders (cardiomyopathies) without adequate  | 
| medical or surgical treatments. | 
|         (7) End-stage liver disease where (i) transplant is not  | 
| a viable option or (ii) transplant rejection or failure has  | 
| occurred. | 
|         (8) End-stage kidney failure where (i) transplant is  | 
| not a viable option or (ii) transplant rejection or failure  | 
| has occurred. | 
|  | 
|         (9) Metabolic or biochemical disorders, including, but  | 
| not limited to, mitochondrial disease, leukodystrophies,  | 
| Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no  | 
| suitable therapies exist or (ii) available treatments,  | 
| including stem cell ("bone marrow") transplant, have  | 
| failed. | 
|         (10) Congenital or acquired diseases of the  | 
| gastrointestinal system, such as "short bowel syndrome",  | 
| where (i) transplant is not a viable option or (ii)  | 
| transplant rejection or failure has occurred. | 
|         (11) Congenital skin disorders, including but not  | 
| limited to epidermolysis bullosa, where no suitable  | 
| treatment exists.
 | 
|     The definition of a life-limiting medical condition shall  | 
| not include a definitive time period due to the difficulty and  | 
| challenges of prognosticating life expectancy in children.  
 | 
|     Section 30. Authorized providers. Providers authorized to  | 
| deliver services under the pilot waiver program shall include  | 
| licensed hospice agencies or home health agencies licensed to  | 
| provide hospice care and will be subject to further criteria  | 
| developed by the Department for provider participation.  At a  | 
| minimum, the participating provider must house a pediatric  | 
| interdisciplinary team that includes a pediatric medical  | 
| director, a nurse, and a licensed social worker.  All members of  | 
| the pediatric interdisciplinary team must submit to the  | 
|  | 
| Department proof of pediatric End-of-Life Nursing Education  | 
| Curriculum (Pediatric ELNEC Training) or an equivalent. 
 | 
|     Section 35. Interdisciplinary team; services. Subject to  | 
| federal approval for matching funds, the reimbursable services  | 
| offered under the pilot program shall be provided by an  | 
| interdisciplinary team, operating under the direction of a  | 
| pediatric medical director, and shall include, but not be  | 
| limited to, the following: | 
|         (1) Pediatric nursing for pain and symptom management. | 
|         (2) Expressive therapies (music and art therapies) for  | 
| age-appropriate counseling. | 
|         (3) Client and family counseling (provided by a  | 
| licensed social worker or non-denominational chaplain or  | 
| spiritual counselor). | 
|         (4) Respite care. | 
|         (5) Bereavement services. | 
|         (6) Case management.
 | 
|     Section 40. Administration.  | 
|     (a) The Department shall oversee the administration of the  | 
| pilot program.  The Department, in consultation with interested  | 
| stakeholders, shall determine the appropriate process for  | 
| review of referrals and enrollment of qualifying participants. | 
|     (b) The Department shall appoint an individual or entity to  | 
| serve as case manager or an alternative position to assess  | 
|  | 
| level-of-care and target-population criteria for the pilot  | 
| program. The Department  shall ensure that the individual  | 
| receives pediatric End-of-Life Nursing Education Curriculum  | 
| (Pediatric ELNEC Training) or an equivalent to become  | 
| familiarized with the unique needs and difficulties facing this  | 
| population.  The process for review of referrals and enrollment  | 
| of qualifying participants shall not include unnecessary  | 
| delays and shall reflect the fact that treatment of pain and  | 
| other distressing symptoms represents an urgent need for  | 
| children with life-limiting medical conditions. The process  | 
| shall also acknowledge that children with life-limiting  | 
| medical conditions and their families require holistic and  | 
| seamless care.
 | 
|     Section 45. Period of pilot program.  | 
|     (a) The program implemented under this Act shall be  | 
| considered a pilot program for 3 years following the date of  | 
| program implementation or, if the pilot program is created  | 
| utilizing a waiver authority, until the waiver that includes  | 
| the services provided under the program undergoes the federally  | 
| mandated renewal process. | 
|     (b)  During the period of time that the waiver program is  | 
| considered a pilot program, pediatric palliative care shall be  | 
| included in the issues reviewed by the Hospice and Palliative  | 
| Care Advisory Board.  The Board shall make recommendations  | 
| regarding changes or improvements to the program, including but  | 
|  | 
| not limited to advisement on potential expansion of the  | 
| potentially life-limiting medical conditions as defined in  | 
| subsection (b) of Section 25. | 
|     (c) At the end of the 3-year pilot program, the Department  | 
| shall prepare a report for the General Assembly concerning the  | 
| program's outcomes effectiveness and shall also make  | 
| recommendations for program improvement, including, but not  | 
| limited to, the appropriateness of the potentially  | 
| life-limiting medical conditions as defined in subsection (b)  | 
| of Section 25.
 | 
|     Section 50. Effect on medical assistance program.  | 
|     (a)  Nothing in this Act shall be construed so as to result  | 
| in the elimination or reduction of any benefits or services  | 
| covered under the medical assistance program under Article V of  | 
| the Illinois Public Aid Code. | 
|     (b)  This Act does not affect an individual's eligibility to  | 
| receive, concurrently with the benefits provided for in this  | 
| Act, any services, including home health services, for which  | 
| the individual would have been eligible in the absence of this  | 
| Act.
 | 
|     Section 90. The Hospice Program Licensing Act  is amended  by  | 
| changing Section 15 as follows:
 | 
|     (210 ILCS 60/15) | 
|  | 
|     Sec. 15. Hospice and Palliative Care Advisory Board. | 
|     (a) The Director shall appoint a Hospice and Palliative  | 
| Care Advisory Board ("the Board") to consult with the  | 
| Department as provided in this Section. The membership of the  | 
| Board shall be as follows: | 
|         (1) The Director, ex officio, who shall be a nonvoting  | 
| member and shall serve as chairman of the Board. | 
|         (2) One representative of each of the following State  | 
| agencies, each of whom shall be a nonvoting member:         the  | 
| Department of
    Healthcare and Family Services, the  | 
| Department of Human Services, and the Department on Aging. | 
|         (3) One member who is a physician licensed to
    practice  | 
| medicine in all its branches, selected from the  | 
| recommendations of a statewide professional society  | 
| representing physicians licensed to practice medicine in  | 
| all its branches in all specialties. | 
|         (4) One member who is a registered nurse,
    selected from  | 
| the recommendations of professional nursing associations. | 
|         (5) Four members selected from the
    recommendations of  | 
| organizations whose primary membership consists of hospice  | 
| programs. | 
|         (6) Two members who represent the general
    public and  | 
| who have no responsibility for management or formation of  | 
| policy of a hospice program and no financial interest in a  | 
| hospice program. | 
|         (7) One member selected from the
    recommendations of  | 
|  | 
| consumer organizations that engage in advocacy or legal  | 
| representation on behalf of hospice patients and their  | 
| immediate families. | 
|     (b) Of the initial appointees, 4 shall serve for terms of 2  | 
| years, 4 shall serve for terms of 3 years, and 5 shall   serve  | 
| for terms of 4 years, as determined by lot at the first meeting  | 
| of the Board. Each successor member shall be appointed for a  | 
| term of 4 years. A member appointed to fill a vacancy before  | 
| the expiration of the term for which his or her predecessor was  | 
| appointed shall be appointed to serve for the remainder of that  | 
| term. | 
|     (c) The Board shall meet as frequently as the chairman  | 
| deems necessary, but not less than 4 times each year. Upon the  | 
| request of 4 or more Board members, the chairman shall call a  | 
| meeting of the Board. A Board member may designate a  | 
| replacement to serve at a Board meeting in place of the member  | 
| by submitting a letter stating that designation to the chairman  | 
| before or at the Board meeting. The replacement member must  | 
| represent the same general interests as the member being  | 
| replaced, as described in paragraphs (1) through (7) of  | 
| subsection (a). | 
|     (d) Board members are entitled to reimbursement for their  | 
| actual expenses incurred in performing their duties. | 
|     (e) The Board shall advise the Department on all aspects of  | 
| the Department's responsibilities under this Act, including  | 
| the format and content of any rules adopted by the Department  | 
|  | 
| on or after the effective date of this amendatory Act of the  | 
| 95th General Assembly. Any such rule  or amendment to a rule  | 
| proposed on or after the effective date of this amendatory Act  | 
| of the 95th General Assembly, except an emergency rule adopted  | 
| pursuant to Section 5-45 of the Illinois Administrative  | 
| Procedure Act, that is adopted without obtaining the advice of  | 
| the Board is null and void. If the Department fails to follow  | 
| the advice of the Board with respect to a proposed rule or  | 
| amendment to a rule, the Department shall, before adopting the  | 
| rule or amendment to a rule, transmit a written explanation of  | 
| the reason for its action to the Board. During its review of  | 
| rules, the Board shall analyze the economic and regulatory  | 
| impact of those rules. If the Board, having been asked for its  | 
| advice with respect to a proposed rule or amendment to a rule,  | 
| fails to advise the Department within 90 days, the proposed  | 
| rule or amendment shall be considered to have been acted upon  | 
| by the Board.
 | 
|     (f) The Board shall also review pediatric palliative care  | 
| issues as provided in the Pediatric Palliative Care Act.  | 
| (Source: P.A. 95-133, eff. 1-1-08.)
 
 | 
|     Section 99. Effective date. This Act takes effect upon  | 
| becoming law.
 |